ReviewIndian journal of urology : IJU : journal of the Urological Society of India
Adrenal myelolipoma: Controversies in its management.
Review in Indian journal of urology : IJU : journal of the Urological Society of India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta-analysis of reported presacral myelolipomas, including a report of a new case.Journal of medical case reports · 2023Pooled it
- Adrenal myelolipoma with severe hemorrhage: a case report.Journal of surgical case reports · 2026Article
- A rare case of non-functional adrenal myelolipoma associated with hypertension: a case report and literature review.International journal of surgery case reports · 2026Article
- Single-nucleus RNA sequencing reveals the cellular composition and the mechanism underlying adrenal myelolipoma.Endocrine · 2026Article
- Preperitoneal Myelolipoma Occurring after Video-Assisted Thoracoscopic Surgery for Thymoma: A Case Report.Surgical case reports · 2026Article
- Laparoscopic adrenalectomy via transperitoneal and retroperitoneal approaches for bilateral giant adrenal myelolipoma: A case report and literature review.Experimental and therapeutic medicine · 2025Article
- Adrenal lipoma formation via PI(3,4,5)PProceedings of the National Academy of Sciences of the United States of America · 2025Article
- Large sized bilateral adrenal myelolipoma with spontaneous retroperitoneal hemorrhage: a case series.Annals of medicine and surgery (2012) · 2025Article
- A Rare Case of Catecholamine-Secreting Adrenal Myelolipoma.Journal of the ASEAN Federation of Endocrine Societies · 2025Article
- Spontaneous hemorrhage in adrenal myelolipoma treated with elective laparoscopic adrenalectomy following selective arterial embolization.IJU case reports · 2025Article
- Management of patients with adrenal myelolipoma: experience from a tertiary referral centre.Irish journal of medical science · 2024Observational
- A hormone secreting adrenal myolipoma in an asymptomatic woman.Urology case reports · 2024Article
- A Rare Case of Giant Bilateral Adrenal Myelolipomas in a Patient With Classical Congenital Hyperplasia.Cureus · 2024Article
- Hemorrhagic giant adrenal myelolipoma discovered incidentally: a case report.Journal of surgical case reports · 2024Article
- Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal Hyperplasia.International journal of molecular sciences · 2024Article
- Article
- A case of adrenal myelolipoma complicated with Prader-Willi syndrome.IJU case reports · 2023Article
- A large adrenal myelolipoma: case report and review of the literature.Journal of surgical case reports · 2023Article
- A case report on a rare presentation of adrenal myelolipoma with low-impact traumatic haemorrhage and the challenges of conservative management.Journal of surgical case reports · 2022Article
- Surgical management and outcome of Extra-adrenal myelolipomas at unusual locations: A report of 11 cases in a single center.Journal of bone oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adrenal myelolipomas (AMLs) are rare, benign neoplasms of the adrenal gland with varied clinical presentations. The rarity of these tumors precludes any case-controlled or randomized study into their management. The available literature is limited to case reports and short series from referral centers. This review is an effort to put the available literature into perspective such that clinical decision making can be done with some clarity. The PubMed and Cochrane databases were searched with key words Adrenal Myelolipoma, Adrenal Incidentaloma (AI) and Adrenal Collision Tumor (ACT). From over 1300 search results, 547 relevant publications dating from 1954 to 2014 were reviewed. Details of about 1231 AMLs in the indexed literature were analyzed. Increasing usage of imaging studies has significantly increased the discovery of AMLs. Although AMLs are benign tumors, those measuring larger than 6 cm are prone to rupture and hemorrhage. Thorough endocrine work-up may benefit a selected group of patients, especially those who are hypertensive, diabetic/pre-diabetic, young patients (<50 years) and those with bilateral AML. Regular observation is needed for AML patients who are being treated non-operatively, as many of them may require surgery during follow-up. Although the AACE/AAES guidelines for AI (2009) exclude AML from mandatory metabolic work-up for a newly discovered AI, we feel that a significant number of patients with AML would benefit from metabolic work-up. In the literature, endocrine dysfunction in AML is 7% as compared with 11% in AI. Endocrine dysfunction in AML is probably underdiagnosed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.